Loss to follow‐up: A significant barrier in the treatment cascade with direct‐acting therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Loss to follow‐up: A significant barrier in the treatment cascade with direct‐acting therapies

Published:2019-12-02 Issue:3 Volume:27 Page:243-260
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Darvishian Maryam¹²³⁴^ORCID,Wong Stanley¹,Binka Mawuena¹,Yu Amanda¹,Ramji Alnoor²,Yoshida Eric M.⁵,Wong Jason¹²,Rossi Carmine¹²,Butt Zahid A.¹²^ORCID,Bartlett Sofia¹²^ORCID,Pearce Margo E.¹²,Samji Hasina¹⁶,Cook Darrel¹,Alvarez Maria¹,Chong Mei¹,Tyndall Mark¹²,Krajden Mel¹²,Janjua Naveed Z.¹²^ORCID

Affiliation:

1. BC Centre for Disease Control Vancouver BC Canada

2. University of British Columbia Vancouver BC Canada

3. BC Cancer Research Centre Vancouver BC Canada

4. Population Oncology Vancouver BC Canada

5. Division of Gastroenterology of the Department of Medicine University of British Columbia Vancouver BC Canada

6. Simon Fraser University Burnaby BC Canada

Funder

Canadian Institutes of Health Research

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13228

Reference50 articles.

1. World Health Organization.Fact sheet hepatitis C.http://www.who.int/mediacentre/factsheets/fs164/en/[Updated April 2017]. Accessed July 18 2017.

2. Natural history of hepatitis C

3. Estimated prevalence of Hepatitis C Virus infection in Canada, 2011

4. Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort

5. Rapid Genotyping of Hepatitis C Virus by Primer-Specific Extension Analysis

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Four weeks of off‐treatment follow‐up is sufficient to determine virologic responses at off‐treatment week 12 in patients with hepatitis C virus infection receiving fixed‐dose pangenotypic direct‐acting antivirals;Journal of Medical Virology;2024-05

2. Reducing Sample Size While Improving Equity in Vaccine Clinical Trials: A Machine Learning-Based Recruitment Methodology with Application to Improving Trials of Hepatitis C Virus Vaccines in People Who Inject Drugs;Healthcare;2024-03-13

3. Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving pangenotypic direct-acting antivirals;2024-01-23

4. Evaluation of the impact of a health-system specialty pharmacy patient management program on achieving predefined clinical outcome measures;American Journal of Health-System Pharmacy;2024-01-03

5. Socio‐economic factors associated with loss to follow‐up among individuals with HCV: A Dutch nationwide cross‐sectional study;Liver International;2023-09-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3